PURETRIG mimics luteinising hormone (LH), triggering ovulation in females and promoting testosterone synthesis in males.
Recommended for:
Ovulation induction in female infertility
Luteal phase deficiency
Male hypogonadotropic hypogonadism
Assisted reproductive techniques (IVF, IUI)
Female and male infertility, anovulatory cycles, hypogonadism, cryptorchidism in children, and adjuvant therapy in assisted reproduction.
Administered via intramuscular or subcutaneous injection by a healthcare provider. Dosage is individually determined based on clinical indications. Often used in combination with other hormonal agents.
Contraindications:
Sex hormone-dependent tumours
Hypersensitivity to HCG
History of thromboembolic disorders
Pregnancy and breastfeeding (unless indicated)
Side Effects:
Injection site pain
Headache
Acne or skin rash
Irritability or restlessness
Rarely, ovarian hyperstimulation syndrome (in women)